n/a
Abstract Title:

Astaxanthin Attenuates Adiponectin, Calprotectin, miRNA222 and miRNA378 in Obesity induced by High-Fat Diet in Rats.

Abstract Source:

Curr Pharm Biotechnol. 2021 Aug 9. Epub 2021 Aug 9. PMID: 34375188

Abstract Author(s):

Sylvia A Boshra

Article Affiliation:

Sylvia A Boshra

Abstract:

BACKGROUND: Astaxanthin suppressed obesity in rats fed with high-fat diet(HFD) via the restriction of adipose tissue build-out, therefore, improving insulin sensitivity and inflammation. Metformin reduces insulin resistance and may reduce weight.

AIM: Investigation of the effects of astaxanthin and metformin in obesity prompted by a high-fat diet.

OBJECTIVE: The present article investigates the effects of astaxanthin and metformin in obesity prompted by a high-fat diet in rats through measuring miRNA222 and 378.

MATERIALS: The rats were classified into four classes containing ten albino rats each: Group I(Normal group): nourished with ordinary diet for 8weeks. Group II(Control positive): nourished with a high-fat diet for 8 weeks. Group III: nourished with astaxanthin(50mg/kg)(1/40 LD50) orally plus a high-fat diet for 8weeks. Group IV: nourished with metformin (500mg/kg) orally plus a high-fat diet for 8 weeks.

METHODS: Leptin, adiponectin, calprotectin and interleukin 6 (IL-6) were assessed by rat-specific ELISA kits. Tumor necrosis factor-alpha (TNF-α), miRNA222 and miRNA378 expressions were quantified by quantitative real-time PCR.

RESULTS: Astaxanthin and metformin have anti-obesity and antioxidant actions and significantly decreased the weight of the body, glucose, insulin, triglycerides, total cholesterol, triglycerides and leptin, as well as plasma calprotectin&IL-6 and increased HDL-C and adiponectin. The liver TNF-αgene expression, adipose tissue miRNA222 and miRNA378 expression were decreased compared to HFD control rats.

DISCUSSION AND CONCLUSION: Astaxanthin has regulated the aberrant expression of miRNA222 and 378 that may be related to hyperlipidemia and insulin resistance. Accordingly, astaxanthin deserves a clinical trial in the future due to its effects on miRNAs involved in obesity.

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.